GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.

[1]  Limin Liu,et al.  Prognostic value and immunological roles of GPX3 in gastric cancer , 2023, International journal of medical sciences.

[2]  S. H. van der Burg,et al.  Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment , 2023, Nature communications.

[3]  Yiming Li,et al.  YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer. , 2023, Cancer letters.

[4]  C. Chung,et al.  Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer , 2022, Journal of Cancer Research and Clinical Oncology.

[5]  Xuetao Cao,et al.  Tumor-polarized GPX3+ AT2 lung epithelial cells promote premetastatic niche formation , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Y. Liao,et al.  Evaluation of stromal cell infiltration in the tumor microenvironment enable prediction of treatment sensitivity and prognosis in colon cancer , 2022, Computational and structural biotechnology journal.

[7]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[8]  X. Xia,et al.  GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  S. Batra,et al.  Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia. , 2021, Cytokine & growth factor reviews.

[10]  De-sheng Wang,et al.  GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma , 2021, Journal for ImmunoTherapy of Cancer.

[11]  Yixin Xu,et al.  Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment , 2021, PeerJ.

[12]  Tingting Song,et al.  Growth differentiation factor-15 promotes immune escape of ovarian cancer via targeting CD44 in dendritic cells. , 2021, Experimental cell research.

[13]  J. Routy,et al.  GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer , 2021, Journal of Cancer.

[14]  N. Hempel,et al.  Extracellular Glutathione Peroxidase GPx3 and Its Role in Cancer , 2020, Cancers.

[15]  Lianjun Lin,et al.  Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors , 2020, Disease markers.

[16]  Xiaole Shirley Liu,et al.  TIMER2.0 for analysis of tumor-infiltrating immune cells , 2020, Nucleic Acids Res..

[17]  W. Fridman,et al.  Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint , 2020, Frontiers in Immunology.

[18]  T. Abraham,et al.  Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cells , 2019, bioRxiv.

[19]  N. Hempel,et al.  GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment , 2018, Redox biology.

[20]  Denis Torre,et al.  BioJupies: Automated Generation of Interactive Notebooks for RNA-seq Data Analysis in the Cloud , 2018, bioRxiv.

[21]  Wei Zhang,et al.  GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer , 2018, BMC Cancer.

[22]  A. Gonzalez-Perez,et al.  A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations , 2017, Clinical Cancer Research.

[23]  K. Choi,et al.  NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells , 2016, Oncotarget.

[24]  S. Shinkai,et al.  Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age‐related disorders , 2016, Geriatrics & gerontology international.

[25]  J. Rokach,et al.  Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid. , 2015, Biochimica et biophysica acta.

[26]  B. Haendler,et al.  Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis , 2014, Cancer medicine.

[27]  Wei Zhang,et al.  Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma , 2014, BMC Cancer.

[28]  E. Giovannucci,et al.  A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer. , 2014, Journal of the National Cancer Institute.

[29]  Lili Wang,et al.  Growth Differentiation Factor-15 Suppresses Maturation and Function of Dendritic Cells and Inhibits Tumor-Specific Immune Response , 2013, PloS one.

[30]  R. Nahta,et al.  Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion , 2012, Biochemical pharmacology.

[31]  Young Jin Choi,et al.  Immunohistochemical evidence for the over-expression of Glutathione peroxidase 3 in clear cell type ovarian adenocarcinoma , 2011, Medical oncology.

[32]  P. Dottino,et al.  Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression , 2011, Journal of ovarian research.

[33]  B. Davidson,et al.  Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer. , 2010, Gynecologic oncology.

[34]  Y. Saga,et al.  Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma. , 2008, Oncology reports.

[35]  S. Baek,et al.  Expression of NAG-1, a Transforming Growth Factor-β Superfamily Member, by Troglitazone Requires the Early Growth Response Gene EGR-1* , 2004, Journal of Biological Chemistry.

[36]  D R Schwartz,et al.  Coordinately up-regulated genes in ovarian cancer. , 2001, Cancer research.

[37]  S. Baek,et al.  Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. , 2001, Molecular pharmacology.

[38]  K. Unsicker,et al.  Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues , 1999, Cell and Tissue Research.